INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $965 | -31.7% | 38,230 | -42.9% | 0.02% | -20.7% |
| Q2 2023 | $1,412 | -35.2% | 66,903 | -47.6% | 0.03% | -43.1% |
| Q1 2023 | $2,178 | -23.5% | 127,765 | -10.3% | 0.05% | -37.0% |
| Q4 2022 | $2,846 | -99.9% | 142,432 | +58.1% | 0.08% | +58.8% |
| Q3 2022 | $1,941,000 | -1.7% | 90,112 | -10.0% | 0.05% | -13.6% |
| Q2 2022 | $1,974,000 | +64.6% | 100,112 | +96.3% | 0.06% | +110.7% |
| Q1 2022 | $1,199,000 | -3.5% | 51,000 | +11.7% | 0.03% | 0.0% |
| Q4 2021 | $1,243,000 | +2.6% | 45,645 | +3.7% | 0.03% | +7.7% |
| Q3 2021 | $1,212,000 | +57.8% | 44,000 | +63.0% | 0.03% | +52.9% |
| Q2 2021 | $768,000 | -2.4% | 26,986 | +16.8% | 0.02% | 0.0% |
| Q1 2021 | $787,000 | -1.6% | 23,111 | -3.9% | 0.02% | +13.3% |
| Q4 2020 | $800,000 | -44.8% | 24,042 | -46.7% | 0.02% | -61.5% |
| Q3 2020 | $1,449,000 | -24.0% | 45,084 | -34.9% | 0.04% | -29.1% |
| Q2 2020 | $1,906,000 | +120.1% | 69,226 | +28.2% | 0.06% | +61.8% |
| Q1 2020 | $866,000 | -19.4% | 54,000 | +20.0% | 0.03% | +88.9% |
| Q4 2019 | $1,075,000 | +56.2% | 45,000 | +15.4% | 0.02% | +28.6% |
| Q3 2019 | $688,000 | -10.4% | 39,000 | +30.0% | 0.01% | -30.0% |
| Q2 2019 | $768,000 | -37.1% | 30,000 | -28.6% | 0.02% | -33.3% |
| Q1 2019 | $1,221,000 | +313.9% | 42,000 | +86.7% | 0.03% | +150.0% |
| Q4 2018 | $295,000 | -77.5% | 22,500 | -65.4% | 0.01% | -65.7% |
| Q3 2018 | $1,314,000 | -28.8% | 65,000 | -16.7% | 0.04% | -20.5% |
| Q2 2018 | $1,845,000 | +17.1% | 78,000 | +11.4% | 0.04% | -12.0% |
| Q1 2018 | $1,576,000 | +1.1% | 70,000 | +40.0% | 0.05% | +25.0% |
| Q4 2017 | $1,559,000 | -50.0% | 50,000 | -50.0% | 0.04% | -65.5% |
| Q3 2017 | $3,121,000 | +1437.4% | 100,000 | +792.9% | 0.12% | +728.6% |
| Q4 2015 | $203,000 | -61.0% | 11,200 | -55.2% | 0.01% | -39.1% |
| Q1 2015 | $520,000 | +126.1% | 25,000 | +106.6% | 0.02% | +360.0% |
| Q1 2014 | $230,000 | +21.7% | 12,100 | +8.7% | 0.01% | +25.0% |
| Q4 2013 | $189,000 | -84.9% | 11,130 | -86.1% | 0.00% | -69.2% |
| Q3 2013 | $1,248,000 | +9.9% | 80,000 | -15.8% | 0.01% | -60.6% |
| Q2 2013 | $1,136,000 | – | 95,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |